BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%

Oct.31
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia's Q3 results show a sharp 89.5% drop in net profit to RM7 million (approximately $150,000 USD), with revenue also falling to RM300 million (approximately $6.4 million USD). The company attributed the decline to new regulatory requirements, including pictorial health warnings and the retail display ban. Its stock dropped 15.25% to RM4.78 (approximately $1.02 USD).

Key Points

 

  • Stock Price Drop: BAT Malaysia's stock dropped 15.25% following the third-quarter report, falling to RM4.78 (approximately $1.02 USD).

 

  • Sharp Profit Decline: Net profit for Q3 dropped to RM7 million (approximately $150,000 USD), a 89.5% decrease year-on-year.

 

  • Revenue Halved: Revenue fell to RM300 million (approximately $6.4 million USD), half of last year's figure.

 

  • Regulatory Pressures: New regulations, including pictorial health warnings and retail display bans, led to significant operational adjustments and investments.

 

2Firsts, October 31, 2025 — British American Tobacco Malaysia (BAT Malaysia) reported a sharp drop in its third-quarter results, with net profit plunging to RM7 million (approximately $150,000 USD), down 89.5% from RM67 million (approximately $1.42 million USD) in the same period last year. Revenue also dropped significantly to RM300 million (approximately $6.4 million USD), compared to RM609 million (approximately $1.3 million USD) in 2024.

 

The company attributed the poor performance to new regulatory requirements, including the implementation of pictorial health warnings and the retail display ban, which led to significant operational adjustments and heavy investments.

 

After the third-quarter report was released, BAT Malaysia's stock price plummeted by 15.25%, reaching RM4.78 (approximately $1.02 USD) as of 11:47 AM on October 31.

 

Despite these challenges, BAT Malaysia's year-to-date cumulative revenue reached RM1.25 billion (approximately $268 million USD), thanks to ongoing cost optimization efforts. Its premium brand Dunhill continued to strengthen its market share, maintaining its leadership in the legal tobacco segment.

 

The company also announced that the board would pay a third interim dividend of 5 sen per share (approximately 1.1 cents), totaling RM14.3 million (approximately $3 million USD), payable on December 5, 2025.

 

BAT Malaysia's Managing Director, Nedal Salem, stated that despite regulatory pressures and declining market volumes, the company remained resilient due to its core combustibles portfolio. He also expressed optimism about the fiscal initiatives announced under Budget 2026, which are expected to increase disposable income and support household consumption. BAT Malaysia will continue to focus on optimizing its portfolio and ensuring long-term sustainability.

 

On April 28, BAT Malaysia announced that it would phase out its existing VUSE e-cigarette products from the Malaysian market, in accordance with the Public Health Control of Smoking Products Act 852, which will come into effect on October 1, 2025. As part of this transition, BAT plans to phase out the VUSE product line by the third quarter of 2025 to comply with the new regulatory requirements.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
NSW Police, together with NSW Health and the Australian Border Force, seized more than 18,000 vapes, 1.9 million cigarettes, 74kg of loose-leaf tobacco and five unregistered firearms during a week of action under Strike Force Franklin. Four people were charged following coordinated raids on the Far North Coast. Police said the operation targeted organised crime networks profiting from illicit tobacco sales, with an estimated street value exceeding $2.35 million(1.54 million US dollars)..
Nov.03 by 2FIRSTS.ai
China Opens 2026 National E-Cigarette Standards Project for Public Submissions
China Opens 2026 National E-Cigarette Standards Project for Public Submissions
The State Administration for Market Regulation (SAMR) and the State Tobacco Monopoly Administration (STMA) jointly announced the launch of the 2026 National Standardization Project for E-cigarettes. The initiative, coordinated by the National Technical Committee on Standardization of E-cigarettes, aims to enhance the industry’s regulatory framework through new standards on manufacturing, storage, distribution, and evaluation.
Nov.27 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
Amid intensified regulation and sweeping market shifts, the U.S. vaping industry is undergoing a profound transformation. In an exclusive interview with 2Firsts, AVM President Allison Boughner discusses how enforcement is reshaping brands, distribution, products, compliance, and U.S.-based manufacturing.
Oct.20
JUUL Plans to Launch New E-cigarette Juul2 in the U.S., Featuring App-Based Identity Verification and Awaiting Regulatory Approval
JUUL Plans to Launch New E-cigarette Juul2 in the U.S., Featuring App-Based Identity Verification and Awaiting Regulatory Approval
JUUL plans to launch Juul2 with biometric protection system in the US, targeting adult smokers while preventing underage use.
Oct.24 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai